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XBP1, Downstream of Blimp-1, Expands the Secretory
Apparatus and Other Organelles, and Increases
Protein Synthesis in Plasma Cell Differentiation
restructuring that allows them to secrete large quantities
of immunoglobulin (Ig) (Calame et al., 2003; Wiest et al.,
1990). Two transcriptional regulators are essential for
plasma cell differentiation: Blimp-1, a transcriptional re-
pressor encoded by the prdm1 gene, and XBP1, a b-ZIP
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XBP1 function within the B cell lineage (Reimold et al.,The differentiation of B cells into immunoglobulin-
2001). These mice possessed B cells that proliferatedsecreting plasma cells is controlled by two transcrip-
and formed germinal centers normally but were dramati-tion factors, Blimp-1 and XBP1. By gene expression
cally impaired in their ability to secrete immunoglobulinprofiling, we defined a set of genes whose induction
in vitro and in vivo in response to T-dependent orduring mouse plasmacytic differentiation is dependent
-independent antigens. Most importantly, these xbp1-on Blimp-1 and/or XBP1. Blimp-1-deficient B cells
deficient mice were devoid of plasma cells, demonstra-failed to upregulate most plasma cell-specific genes,
ting the requirement for XBP1 in plasmacytic differenti-
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induced Blimp-1 normally but failed to upregulate XBP1 is also associated with the unfolded protein
genes encoding many secretory pathway compo- response (UPR; Calfon et al., 2002; Fewell et al., 2001;
nents. Conversely, ectopic expression of XBP1 in- Harding et al., 2000; Mori, 2000; Shen et al., 2001; Yo-
duced a wide spectrum of secretory pathway genes shida et al., 2001), a coordinated change in gene expres-
and physically expanded the endoplasmic reticulum. sion that is triggered by perturbations in the function
In addition, XBP1 increased cell size, lysosome con- of the endoplasmic reticulum (ER). Experimentally, the
tent, mitochondrial mass and function, ribosome num- UPR can be induced by DTT, which disrupts protein
bers, and total protein synthesis. Thus, XBP1 coordi- folding in the ER; tunicamycin, which disrupts glycosyla-
nates diverse changes in cellular structure and tion and folding in the ER; and thapsigargin, which de-
function resulting in the characteristic phenotype of pletes ER calcium stores (Fewell et al., 2001; Harding
professional secretory cells. et al., 2001). Overexpression or misfolding of ER proteins
can also elicit the UPR (Kozutsumi et al., 1988).
Introduction The UPR was first characterized in yeast, where a
single signaling pathway governs the response to ER
When B cells become plasma cells, they lose expression stress (Cox et al., 1993; Patil and Walter, 2001). In this
of most B cell characteristics and undergo a radical pathway, the ER stress signal is transduced by a type I
transmembrane ER protein, IRE1. The ER lumenal por-
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pears to be the only substrate. Interaction of IRE1 with ATF6 is not clear at present since recent studies showed
the ER chaperone Kar2p/BiP prevents IRE1 multimeriza- that the activation of several UPR genes (BiP, chop,
tion and autophosphorylation. Current models propose grp94, and xbp1) was unaffected in cells in which ATF6
that during an UPR, BiP is preferentially bound to mis- levels were diminished by RNA interference (Lee et
folded client proteins, thereby releasing IRE1 to multi- al., 2003).
merize and autophosphorylate. In the present study, we used gene expression profil-
IRE1 phosphorylation is accompanied by activation of ing to study the terminal differentiation of B cells derived
an endoribonuclease activity in its cytoplasmic domain, from Blimp-1-deficient and XBP1-deficient mice in order
which mediates the posttranscriptional processing of to elucidate the roles of these transcription factors in
the mRNA encoding HAC1, the yeast ortholog of XBP1. plasma cell development. We observed that XBP1 acted
IRE1 removes a 252 nucleotide internal sequence from downstream of Blimp-1 to regulate a broad complement
HAC1 mRNA, and tRNA ligase rejoins the two fragments of genes encoding ER-associated proteins, many of
of HAC1 mRNA. This new version of HAC1 mRNA is which are involved in protein secretion. XBP1 induced
translated more efficiently than the unprocessed form a dramatic physical expansion of the ER but also, unex-
and encodes a more stable protein with greater tran- pectedly, increased cell size, organelle biogenesis, and
scriptional activation potential (Chapman and Walter, total protein synthesis, thus demonstrating that XBP1
1997; Cox and Walter, 1996; Kawahara et al., 1998; Mori plays a central role in defining the secretory cell phe-
et al., 2000; Sidrauski and Walter, 1997). This linear UPR notype.
pathway is solely responsible for the upregulation of
yeast UPR genes, which encode proteins involved in Results
nearly every aspect of the secretory pathway, including
protein entry into the ER, folding, glycosylation, ER- Regulation of Plasma Cell Gene Expression
associated degradation (ERAD), and vesicular traffick- by Blimp-1 and XBP1
ing (Fewell et al., 2001; Travers et al., 2000). Lipopolysaccharide (LPS) treatment of mouse mature
In higher eukaryotes, ER stress stimulates three dis- splenic B cells in vitro is an established experimental
tinct but overlapping signaling pathways by activating system for studying plasma cell differentiation (Lafrenz
IRE1, PERK, and ATF6 (Harding et al., 2002; Ma and et al., 1982; Schliephake and Schimpl, 1996). After 4
Hendershot, 2003). The IRE1 UPR pathway has been days in culture, approximately 30% of cells achieve a
maintained in higher eukaryotes with some modification. plasma cell phenotype (surface expression of synde-
Activated IRE1 functions in mammals by removing 26 can-1 and immunoglobulin secretion; M.S.-S. and N.N.I.,
nucleotides from the XBP1 mRNA. This new mRNA en- unpublished data). To identify genes induced during dif-
codes a protein with increased transcriptional activation ferentiation and to determine their dependence on
potential (Calfon et al., 2002; Shen et al., 2001; Yoshida Blimp-1 and XBP1, we compared gene expression pro-
et al., 2001). XBP1 induces several UPR response genes, files from LPS-treated wild-type (wt), prdm1-deficient,
similar to those induced by HAC1 in yeast (Lee et al., and xbp1-deficient B cells (Reimold et al., 2001; Shapiro-
2003; Yoshida et al., 2003). However, mouse embryo
Shelef et al., 2003). For these studies, we constructed
fibroblasts lacking IRE1 still upregulate several UPR
the mouse Lymphochip, a specialized DNA microarray
genes in response to ER stress, including BiP and chop,
analogous to the human Lymphochip (Alizadeh et al.,
indicating that IRE1 is not the sole mediator of the UPR
1999), which is enriched for genes expressed in normal
in higher eukaryotes (Harding et al., 2002).
lymphocytes and for genes that play important roles inSome UPR functions are mediated by PERK, a trans-
the immune system. Since only a fraction of the B cellsmembrane ER kinase (Harding et al., 1999, 2001). Like
in these cultures differentiate to plasma cells, it wasIRE1, PERK interacts with BiP via its ER lumenal domain,
not possible to monitor decreases in the expression ofkeeping PERK’s cytoplasmic kinase domain inactive.
genes in the plasma cells, but the induction of plasmaBiP is dissociated from PERK during an UPR, which
cell genes was readily measured. After applying confi-activates PERK to phosphorylate the key translation ini-
dence criteria for each element, we focused our analysistiation factor eIF2. eIF2 phosphorylation acutely in-
on those genes that required prdm1 or xbp1 for maximalhibits protein translation globally, thereby lessening the
induction and were also more highly expressed inload of proteins entering the ER. However, phosphory-
plasma cells as compared to B cells (Figure 1; Sup-lated eIF2 allows for the alternative translation initiation
plemental Figure S1 at http://www.immunity.com/cgi/of ATF4, a transcription factor that in turn transactivates
content/full/20/2/81/DC1 and http://lymphochip.nih.gov/UPR genes, such as chop and BiP, and is the only known
ShafferPCfactors/). To capture the most reliable data,gene to be regulated in this fashion by PERK (Harding
our analyses included only those genes that consistentlyet al., 2003).
failed to be induced in factor-deficient B cells as com-A third UPR pathway is initiated by ATF6, a type II ER
pared to wt B cells by at least 1.8-fold, which representstransmembrane protein (Haze et al., 1999; Yoshida et
a difference in induction of approximately 5-fold whenal., 2000). Two forms of ATF6,  and , exist in mamma-
the number of differentiating cells in each culture (ap-lian cells and both are localized to the ER in unstressed
proximately 30%) is taken into account.cells by association with BiP. Upon UPR induction, ATF6
Comparison of wt and prdm1-deficient B cells identi-is released by BiP and exported to the Golgi, where it
fied 54 genes that required Blimp-1 for induction (Figureis cleaved by intramembrane proteases, releasing its
1A). Comparison of wt and xbp1-deficient B cells re-cytoplasmic domain. This portion of ATF6 acts as a
vealed 36 genes as downstream targets of XBP1 (Figuretranscriptional activator that can increase expression of
1B). Notably, xbp1 mRNA expression was induced inER chaperones and XBP1 (Okada et al., 2002; Shen et
al., 2001; Yoshida et al., 2000, 2003). The exact role of wt but not prdm1-deficient B cells. On the other hand,
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Figure 1. The Roles of prdm1 and xbp1 in Promoting Gene Expression during Plasma Cell Differentiation
RNA extracted from purified, LPS-treated wt, prdm1-, or xbp1-deficient splenic B cells was converted to labeled cDNA (Cy5, red) and
cohybridized on mouse lymphochips with cDNA generated from a common reference pool of mouse cell line RNA (Cy3, green). Hybridization
was measured by laser scanning (Axon Genepix 4000) and converted to a gene expression ratio (Cy5 experimental/Cy3 control), permitting
the direct comparison of all samples by hierarchical clustering. Data were normalized to unstimulated (time zero) controls for each time course.
When genes were represented by multiple array elements, data for a single representative feature is displayed. A color bar depicts the
magnitude of gene expression differences. (A) Genes whose induction was diminished in prdm1-deficient B cells by at least 1.8-fold versus
wt at days 2 or 4 in 2 of 3 experiments. (B) Genes whose induction was diminished in xbp1-deficient B cells versus wt by at least 1.8-fold in
both experiments at days 2 or 4 of culture. *, prdm1 and Ig light chain expression is affected less than 1.8-fold by the absence of xbp1
(see Results).
prdm1 mRNA expression was induced equally in wt and noglobulin secretion (Figures 1 and 2). Some of these
genes have previously been identified as XBP1 targetsxbp1-deficient B cells (Figure 1B). These observations
confirm that Blimp-1 is upstream of XBP1 in the regula- and are induced during the UPR (Edem, DnaJc3, Armet,
Cai, Hspa5; Lee et al., 2003; Yoshida et al., 2003). How-tory cascade of terminal B cell differentiation, consistent
with previous observations (Shaffer et al., 2002; Shapiro- ever, many of these genes have not been formally asso-
ciated with the response to ER stress and encode aShelef et al., 2003).
To better assess the contribution of Blimp-1 and XBP1 variety of secretory pathway proteins that play roles in
targeting proteins to the ER (srp9), translocation of newlyto the induction of differentiation-associated genes, we
calculated the difference in expression of each gene synthesized proteins into the ER (sec61a, sec61g, ssr4),
folding of ER proteins (fkbp14, ppib, grp58, txndc5,from Figure 1 between wt B cells and prdm1- or xbp1-
deficient B cells at day 4 following LPS stimulation. Fig- dnaJb9), ER protein degradation by the ERAD pathway
(edem, sel1h, hrd1), protein glycosylation (dad1, fut8,ure 2 depicts the difference in expression for each gene
between wt and prdm1-deficient B cells (black bars) slc33a1, man1b1, b4galt2, mgat2), and vesicle traffick-
ing (arhq, cope, vdp, arcn1). The expression of most (28and wt and xbp1-deficient B cells (gray bars). Most dif-
ferentiation genes (46 of 63) required both prdm1 and of 31) of the secretory pathway genes depended on
both prdm1 and xbp1, suggesting that XBP1, actingxbp1, and these are most likely downstream targets of
XBP1, since xbp1 itself was not induced in the absence downstream of Blimp-1, plays a critical role in coordinat-
ing secretory function.of prdm1. Secretory pathway genes represented the
largest functional category of prdm1- and xbp1-depen- Several (16 of 63) plasma cell-associated genes (e.g.,
syndecan-1, sdc1) required only prdm1 for their induc-dent genes (28), emphasizing the importance of these
regulatory factors in preparing cells for high-level immu- tion, suggesting that Blimp-1 controls part of the plasma
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Figure 2. Plasma Cell Gene Induction: Dependence on prdm1 and/or xbp1
The average gene expression ratio at day 4 of LPS culture was calculated for each element identified in Figure 1. The difference in expression
of each gene between wt B cells and prdm1- (black) or xbp1-deficient (gray) B cells is plotted as a bar graph. Bars to next to each graph
show the dependence of gene expression on prdm1 and/or xbp1. An (h) indicates the likely mouse ortholog of the human gene.
cell gene expression program in an XBP1-independent not XBP1-u in a statistically significant fashion (paired
Student’s t test, p  0.025) and were also more highlyfashion (Figure 2). Finally, two genes appeared to de-
pend on XBP1 but not Blimp-1 and are perhaps sensitive expressed in primary human plasma cells as compared
to other mature B cell populations (Wright et al., 2003;to low levels of Blimp-1-independent XBP1 activation.
Supplemental Figure S2).
Figure 3A shows genes upregulated by XBP1-s butXBP1 Promotes ER Expansion
To explore further the role of XBP1 in regulating gene not XBP1-u in Raji cells. XBP1-s induced many of the
same genes that were found to be xbp1-dependent inexpression, we used retroviral transduction to express
human XBP1 in cell lines that lack expression of the the mouse (indicated by an “*”). Genes found to be
prdm1-dependent but xbp1-independent in the mouseendogenous xbp1 gene. Retroviruses bearing a puromy-
cin selectable marker were engineered to coexpress the (e.g., syndecan-1) were not induced by XBP1-s expres-
sion in Raji cells, supporting the notion that Blimp-1transcriptionally active, processed form of human xbp1
mRNA (XBP1-s) or a form of xbp1 mRNA that cannot alone regulates these genes. Secretory pathway genes
again dominate the list of XBP1-s-induced genes (Figurebe processed by IRE1 (XBP1-u) (Iwakoshi et al., 2003b),
which encodes an unstable and transcriptionally inac- 3A). These encode proteins involved in translocation of
proteins across the ER membrane (srp54, srpr, ssr3,tive factor. Retroviruses expressing only the puromycin
resistance gene were used for control transductions. ssr4, rpn1, tram1, spc22/23), ER protein folding (erp70,
ppib, grp58, fkbp11, dnaJb9, hspa5), protein glycosyla-The human mature B cell line Raji, which expresses
little active XBP1-s (A.-H.L., unpublished data), was in- tion (gcs1, ddost, dad1), and vesicle trafficking (sec23B,
sec24C, os-9, golgB1, mcfd2). XBP1-s also upregulatedfected with control, XBP1-s-, or XBP1-u-expressing re-
troviruses, and gene expression changes were moni- ER/secretory pathway genes when introduced into the
human kidney cell line 293 and the mouse B cell linetored using human Lymphochip cDNA microarrays
(Alizadeh et al., 1999; Figure 3). Multiple independent WEHI-231 (Figures 3B and 3C), suggesting that the pro-
gram of secretory gene expression is inherent to XBP1-sexperiments were performed using the XBP1-s (8) and
XBP1-u retroviruses (4), allowing the identification of irrespective of cell type. A number of genes with diverse
functions are also upregulated by XBP1-s expression.genes whose expression was altered by XBP1-s but
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Figure 3. XBP1-s Target Genes
(A) RNA from RAJI cells transduced with ret-
rovirus encoding the active form (XBP1-s) or
an unsplicable, unstable form (XBP1-u) of hu-
man XBP1 was converted to labeled cDNA
(Cy5, red), and cohybridized with cDNA gen-
erated from cells transduced with control
retrovirus (Cy3, green). Eight independent
XBP1-s transductions and four independent
XBP1-u transductions were analyzed on hu-
man lymphochips (Alizadeh et al., 1999)
against control transductions. Average ex-
pression ratios for each gene were calcu-
lated (XBP1-s/control and XBP1-u/control),
and the difference between groups (Ave.
XBP1-sAve. XBP1-u) is shown, with a color
bar indicating its magnitude.
(B) The average expression of genes induced
at least 1.8-fold in two independent transduc-
tions comparing 293 cells transduced with
control (Cy3) or XBP1-s (Cy5) retroviruses.
(C) The average expression of genes induced
at least 1.8-fold in two independent transduc-
tions comparing WEHI-231 cells transduced
with control (Cy3) or XBP1-s (Cy5) retrovi-
ruses, measured on mouse lymphochips. *,
indicates XBP1 target genes from Figures 1
and 2.
Some (armet, prdx4, glrx1) were also identified in the were stained with DiOC6, a marker of ER and mitochon-
dria (Figure 4C; Terasaki et al., 1984). The stained areamouse differentiation system as xbp1 dependent. The
consistent appearance of these genes in two indepen- was greatly expanded in cells expressing XBP1-s (white
arrow). To further confirm the XBP1-s-driven ER expan-dent systems suggests conserved functions for XBP1-s
beyond induction of secretory pathway genes. sion, we transiently expressed a green fluorescent pro-
tein (GFP) with an added signal sequence and KDEL ER-We further confirmed several of these genes as
XBP1-s targets by independently measuring their induc- retention motif in Raji control- and XBP1-s-expressing
cells (Figure 4D). Consistent with the preceding results,tion using quantitative RT-PCR (Supplemental Figure
S3). The dependence of these genes on XBP1 expres- the ER-retained GFP painted a small area in control cells
that expanded substantially when XBP1-s was ex-sion was also confirmed by RNA interference. Expres-
sion of an shRNA directed against XBP1 in the XBP1- pressed.
During our analysis of XBP1-induced ER expansion,expressing human multiple myeloma line H929 decreased
XBP1 expression by nearly 3-fold and shows a concomi- we also noted that cell size increased dramatically, as
quantitated by measuring cell diameter (Figures 5A andtant drop in expression of ER-related and other XBP1-
s-induced genes (Supplemental Figure S3). 5B). The XBP1-induced increase in cell size was ob-
served in both B cells (RAJI, WEHI231) and non-B cellsGiven the profound change in secretory pathway gene
expression mediated by XBP1 in both mouse and human (WS1). Furthermore, knockdown of XBP1 expression in
a myeloma cell line by RNA interference decreased cellcells, it seemed likely that it may also mediate an expan-
sion of the ER and Golgi compartments. We observed size, demonstrating that in cells that constitutively ex-
press XBP1-s, XBP1 maintains cell size. XBP1-s expres-changes in the light scattering properties of cells ex-
pressing XBP1-s consistent with an increase in organ- sion also increased nuclear size and nucleolar promi-
nence (yellow arrows, Figure 5B). The increase in nuclearelle content, while interference with XBP1 expression in
H929 myeloma cells resulted in a decrease in side scat- size was not due to increased DNA content or an arrest
of cells in the G2/M phase of the cell cycle as determinedter (Figure 4A). To specifically assess the expansion of
the secretory apparatus, we stained cells with fluores- by cell cycle analysis (data not shown).
Given that XBP1 expression dramatically increasedcent brefeldin A (BFA-BODIPY; Deng et al., 1995), which
stains both the ER and Golgi. Expression of XBP1-s ER content and cell size, we next looked for XBP1-s-
related changes in other organelles. The bifluorescentincreased fluorescence by 2- to 3-fold in each cell type
tested (Figure 4B), consistent with increased ER mass dye JC1 emits green fluorescence as a function of mito-
chondrial mass (Smiley et al., 1991). By depolarizingassociated with plasma cell differentiation (Wiest et
al., 1990). mitochondria with the ionophore CCCP and staining
with JC1, we observed that XBP1-s expression in-To directly visualize this apparent ER expansion, cells
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Figure 4. XBP1-s Induces ER Expansion
Phenotypic changes in cells transduced with control, XBP1-s-, or shRNA XBP1-expressing retroviruses.
(A) Side scatter of live cells.
(B) ER/Golgi content measured by staining with BFA-BODIPY.
(C) ER expansion in Raji visualized by microscopy after staining with DiOC6 (white arrow indicates expanded ER).
(D) Control and XBP1-s-expressing Raji cells were transduced with an expression vector for an ER-targeted form of GFP, counterstained with
DAPI to identify nuclei (blue), and analyzed by fluorescent microscopy.
creased mitochondrial mass by approximately 40% (Fig- which are glycosylated, we attempted to distinguish be-
tween the synthesis of glycoproteins and nonglycopro-ure 5C). Using another vital dye to assess mitochondrial
function (mitotracker red; Poot and Pierce, 1999), we teins. We removed glycoproteins based on their ability
to bind to the agarose-coupled lectin concanavalin Asaw a concomitant 2.5-fold increase in mitochondrial
respiration (Figure 5D). Cells expressing XBP1-s also (ConA), and the specificity of glycoprotein capture was
confirmed by elution of ConA binding proteins withhad an increase in perinuclear, punctate red staining
with acridine orange, a hallmark of lysosomes (Klint- -methyl mannoside (data not shown). By SDS-PAGE
analysis, however, it appeared that some nonglycopro-worth et al., 1979; data not shown). The XBP1-induced
increase in lysosomal content was confirmed by flow teins (e.g., actin) also bound to ConA, presumably
through their interactions with glycoproteins (data notcytometry of lysotracker red-stained cells (Figure 5E).
These striking changes in cellular structure prompted shown). With this in mind, we observed that XBP1 in-
creased the synthesis of non-ConA binding, nonglyco-us to investigate whether XBP1 expression also altered
cellular protein content. Raji cells expressing XBP1-s sylated proteins to the same extent as observed for all
proteins (Figure 6B), leading us to conclude that expres-had a 50% increase in protein content per cell compared
to control cells (Figure 6A). We next measured how the sion of XBP1-s increases total protein synthesis, not
only the synthesis of glycosylated, ER-targeted pro-expression of XBP1-s affected protein synthesis. Pro-
teins were labeled by incubating cells with 3H-leucine for teins.
The increase in total protein synthesis mediated byincreasing times. To minimize the confounding effects of
protein degradation, radiolabeling was performed in the XBP1-s was associated with an increase in the number
of assembled ribosomes (80S) per cell compared to con-presence of MG132, a potent inhibitor of proteasomes,
lysosomal proteases, and calpains. Raji cells expressing trol or XBP1-u-expressing cells (Figure 6C). This was
not accompanied by an overall induction of ribosomalXBP1-s had approximately 50% higher protein synthesis
than control cells (Figure 6B), whereas expression of gene expression (data not shown). It is possible that
the increase in assembled ribosomes is related to theXBP1-u had little effect. Since XBP1-s induces the ex-
pression of many ER-targeted gene products, many of condensation and prominence of nucleoli, the sites of
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Figure 5. XBP1-s Induces Changes in Cell Size, Structure, and Organelle Content
(A) The average maximum diameter of control and XBP1-s-expressing cells was measured from four to six independent fields of at least five
cells each.
(B) Cells transduced with control or XBP1-s retroviruses were cytospun onto glass slides, fixed, and stained with DIFFQUIK reagents for
microscopy: white arrow, increased cytoplasmic volume; black arrows, perinuclear vacuoles; and yellow arrows, expanded nucleus with
prominent nucleoli.
(C) Mitochondrial mass measured by flow cytometry after depolarization using CCCP followed by staining with JC1.
(D) Mitochondrial function assessed by flow cytometry after incubating cells with mitotracker red.
(E) Lysosomal content measured by flow cytometry after staining cells with lysotracker red.
ribosomal biogenesis, in XBP1-s-expressing cells (Fig- tween glycosylated and nonglycosylated proteins, we
found that XBP1-s expression had little effect on nongly-ure 5B, yellow arrows). However, it is not clear at present
whether this increase in ribosomal content can account coprotein degradation, which remained near 9% across
all samples (Figure 6D). This suggests that the XBP1-s-for the increased protein synthesis, since the overall
loading of mRNAs onto polysomes in these cells was associated decrease in protein degradation is the result
of a specific decrease in glycoprotein degradation.extremely low and therefore difficult to accurately quan-
titate by ultracentrifugation (data not shown).
We next examined the effects of XBP1-s on protein
degradation in Raji cells by radiolabeling cells for 5 min Discussion
with 35S-methionine and chasing with unlabeled methio-
nine for 30 min. Protein degradation was monitored by We have used gene expression profiling to understand
how two transcription factors, Blimp-1 and XBP1, con-measuring the loss of cell-associated and secreted TCA-
insoluble radioactivity in the presence and absence of trol plasma cell differentiation. Most plasma cell genes
were under the control of Blimp-1. Many of these werethe proteosome inhibitor MG132 over time. In control
cells, over 30% of labeled proteins were degraded dur- also targets of XBP1 and promote the entry, processing,
and movement of proteins through the secretory path-ing the 30 min chase period (Figure 6D), which reflects
the rapid proteasome-mediated destruction of newly way. Furthermore, XBP1 expression was sufficient to
induce many phenotypic changes that characterizesynthesized proteins (Schubert et al., 2000). Expression
of XBP1-s reduced the fraction of rapidly degraded plasmacytic differentiation: increased cell size, ex-
panded organelle mass and function, and increased pro-newly synthesized proteins by approximately 40%, from
31% in control cells to 19% with XBP1-s expression, tein synthesis. These findings suggest that the role of
XBP1 in higher eukaryotes has been extended beyondwhereas expression of XBP1-u had little effect on the
rate of degradation. Using ConA to discriminate be- its role in the ER stress response and that XBP1 may
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Figure 6. XBP1-s Effects on Protein Synthesis and Degradation
Raji cells transduced with control, XBP1-s-, or XBP1-u-expressing retroviruses were selected and used for the analysis of protein synthesis
and degradation.
(A) Cells were lysed by sonication and soluble protein content per cell was measured by absorbance using the Bradford assay.
(B) The rate of protein synthesis was measured by incubating cells with 3H-leucine in the presence of proteosome inhibitor and tracking
radioactive amino acid incorporation over time. Proteins were also separated into two fractions based on the binding to ConA (glycosyslated
and nonglycosylated), and the rate of nonglycosylated protein synthesis is shown.
(C) Assembled (80S) ribosomal content measured per cell by absorbance (260 nm) after arresting translation and separating cellular components
by centrifugation through a continuous sucrose gradient. Maximum peak absorbance of the 80S fraction from three independent experiments
is shown.
(D) Total protein degradation measured in cells pulsed with S35-methionine and chased with unlabeled amino acids in the presence and
absence of proteosome inhibitor. Proteins were separated into two fractions based on binding to ConA. The percentage of total and Con-A
nonbinding (nonglycosylated) proteins degraded is shown for a single representative experiment.
be better viewed as a key regulator of the professional marker Syndecan-1. By contrast, virtually all of the
plasma cell genes that required XBP1 for their expres-secretory cell phenotype (Figure 7).
sion also required Blimp-1. Further, xbp1 was not in-
duced in prdm1/ cells, but prdm1 was induced inBlimp-1 Acts Upstream of XBP1 to Regulate
Plasma Cell Gene Expression xbp1/ cells. Together, these findings suggest a regula-
tory hierarchy during plasmacytic differentiation inBlimp-1, a transcriptional repressor, was required for the
induction of most plasma cell genes during plasmacytic which XBP1 acts downstream of Blimp-1. Consistent
with this model, ectopic expression of XBP1 does notdifferentiation. This seemingly paradoxical result is most
readily explained by the ability of Blimp-1 to repress restore a plasma cell phenotype in prdm1-deficient B
cells, though ectopic Blimp-1 does (Shapiro-Shelef etgenes that encode repressors of plasma cell genes. This
“derepression” model of Blimp-1 action has been most al., 2003).
Blimp-1 was required for maximal induction of Igclearly elucidated for two plasma cell genes, J chain
and xbp1, both of which are repressed by PAX5 (Reimold genes (Figures 1 and 2), which may be partially explained
by the repression of pax5, since Pax5 represses expres-et al., 1996; Rinkenberger et al., 1996). Since pax5 is
repressed by Blimp-1, induction of J chain and xbp1 sion from these Ig loci (Shaffer et al., 1997; Singh and
Birshtein, 1996). Another potential mechanism could in-depends on Blimp-1 expression in plasma cells (Lin et
al., 2002; Shaffer et al., 2002). volve the Blimp-1-dependent induction of bob1, a tran-
scriptional coactivator that regulates a 3 Igh enhancerA number of plasma cell genes of diverse function
required Blimp-1 but not XBP1 for their expression, in- (Andersson et al., 2000) and a subset of Ig promoters
(Casellas et al., 2002) (Figures 1 and 2). Blimp-1 but notcluding sdc1, which encodes the standard plasma cell
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Figure 7. A Model for the Regulatory Biology of Plasma Cell Differentiation
Blimp-1 acts upstream of XBP1 to initiate plasma cell differentiation. ER stress in a nonsecretory cell induces an “ER-stress” UPR in which
XBP1, PERK, and ATF6 are activated, leading to decreased ER stress or apoptosis (red box). Alternatively, XBP1 activation in a differentiating
secretory cell initiates a “physiological” UPR that antagonizes the effects of PERK on translation, perhaps by inducing DNAJC3. XBP1 also
coordinately alters the cell structure and function to create a professional secretory cell. Together, the activities of Blimp-1 and XBP1 drive
plasma cell differentiation (green box).
XBP1 is also required for the switch in the usage of Igh suggests that XBP1 regulates essentially every stage of
the secretory process, including the targeting of proteinsmRNA polyadenylation sites, shifting expression from
to the ER (srp9, srp54, rpn1), translocation of proteinsthe membrane-bound to the secreted form of Ig heavy
across the ER membrane (ssr1, ssr3, ssr4, srpr, tram1,chain (Alt et al., 1980; Early et al., 1980; Reimold et al.,
sec61a, sec61g), cleavage of signal peptides (spc22/23,2001; Rogers et al., 1980; Shapiro-Shelef et al., 2003).
h13/spp), folding of ER proteins (dnaJb9, hspa5/BiP,Although the factor(s) mediating this important switch
erp70, grp58, pdir, txndc5, fkbp11, ppib), degradationare unknown, an interesting candidate is the RNA poly-
of misfolded ER proteins by the ERAD pathway (edem,merase II processivity factor ELL2 (Shilatifard et al.,
sel1h), protein glycosylation (slc33a1, ddost, gcs1,1997) that we found to be induced during plasmacytic
man1b1, siat7d, dad1, slc33a1, b4galt2, mgat2, fut8),differentiation in a Blimp-1-dependent fashion (Figures
ER-Golgi vesicular trafficking (cope, os-9, sec24C,1 and 2). The substantial number of genes, like ell2, that
sec23B, golgb1, mcdf2, vdp, arcn1), endosomal traffick-depend exclusively on Blimp-1 for induction (Figure 2)
ing (rabac1), and targeting of secretory vesicles to thepoint to its unique and essential role in promoting
plasma membrane (arhq/tc10). Importantly, XBP1 in-plasma cell differentiation.
duces the expression of many components of the multi-
protein chaperone complex that binds and processes
XBP1 and Biogenesis of the Secretory Apparatus nascent Ig heavy chains (Erp72, Hsp40 homologs, PDI,
Previous work has demonstrated that XBP1, as well as PPIB, Bip) (Meunier et al., 2002), which may specifically
its yeast homolog HAC1p, regulate ER stress-induced contribute to the increased efficiency of Ig secretion.
genes that promote folding of ER proteins and degrada- Interestingly, gene expression profiling experiments in
tion of misfolded ER proteins through the ERAD pathway yeast cells experiencing ER stress suggested a similarly
(Lee et al., 2003; Mori et al., 1998; Yoshida et al., 2003). broad role for HAC1 in the secretory pathway (Travers
Recent studies have also shown that there is overlap in et al., 2000). During the yeast UPR, HAC1 induces a host
the genes induced during plasmacytic differentiation of genes involved in protein translocation into the ER,
and those induced by ER stress (Gass et al., 2002; Iwa- glycosylation, ER protein folding, ER protein degrada-
koshi et al., 2003a; Lee et al., 2003; van Anken et al., tion in the ERAD pathway, vesicular transport, and phos-
2003). pholipid biosynthesis. Since not every secretory path-
The present study defines an expanded role for XBP1 way gene was upregulated by the UPR in yeast, HAC1
in enhancing the secretory capacity of plasma cells. A may be devoted to remodeling the secretory pathway
remarkably consistent set of XBP1 target genes to specifically cope with an excess of unfolded proteins
emerged from studies of xbp1-deficient mouse B cells (Travers et al., 2000). Another interesting aspect of this
and ectopic XBP1 expression, many of which encode study was the finding that mutations in the UPR pathway
and the ERAD pathway were synthetically lethal underproteins that function in the secretory pathway. Our data
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normal growth conditions, revealing a role for HAC1 and Therefore, the increase in protein synthesis caused by
XBP1 cannot be explained by upregulation of mRNAsthe “UPR” in the absence of overt ER stress.
XBP1 has not only retained the broad, UPR-related, encoding glycosylated proteins in the secretory path-
way but must be due to a more general mechanism.transcriptional program of HAC1 but also has the ability
to physically expand the ER compartment. In both One possible scenario involves the XBP1 target gene
DNAJC3 (this study and Lee et al. [2003]), which encodeslymphoid and epithelial cell lines, ectopic XBP1 dramati-
cally augmented the ER, and in myeloma cells, knock- p58IPK, an inhibitor of PERK (van Huizen et al., 2003; Yan
et al., 2002). When PERK is activated, it phosphorylatesdown of XBP1 diminished the ER. Notably, IRE1 and
HAC1 are required for the induction of a specialized form eIF2, leading to decreased translation initiation of most
proteins. Therefore, the upregulation of p58IPK by XBP1of ER known as karmellae that is formed in response to
forced overexpression of ER proteins (Cox et al., 1997). could increase total protein synthesis by antagonizing
PERK (Figure 7). XBP1 also increased the abundanceIn multicellular eukaryotes, unlike yeast, terminal differ-
entiation in some cell lineages results in a “professional” of assembled ribosomes per cell, which might contribute
to the increase in total protein synthesis, and it is possi-secretory cell that has an expanded ER as a fixed attri-
bute. We propose that the function of HAC1 in inducing ble that the condensation of nucleoli that we observed
in XBP1-expressing cells may play a role in this process.ER biogenesis under stress conditions has been
adapted in evolution to allow XBP1 to stably increase Interestingly, plasma cells are characterized by increased
nuclear size and the presence of a single prominentER size during secretory cell differentiation. In keeping
with this hypothesis, XBP1 is not only highly expressed nucleolus (Benjamin et al., 1984), features that may be
attributable to XBP1.in plasma cells but also in secretory tissues such as
the exocrine pancreas and salivary glands (Clauss et
al., 1993). Evolution of XBP1 as a Master Regulator
of Secretory Cell Differentiation
Whereas yeast have a single pathway that senses un-XBP1: Beyond the Endoplasmic Reticulum
Unexpectedly, ectopic expression of processed XBP1 folded proteins in the ER, multicellular eukaryotes have
evolved three parallel pathways: IRE1/XBP1, PERK/in diverse cell lines increased overall cell size and, con-
versely, knockdown of XBP1 expression by RNA inter- ATF4, and ATF6. In evolution, the creation of parallel
pathways by genome duplication can set the stage forference in a myeloma cell line decreased cell size. In
part, these findings could be explained by the ER expan- subsequent functional specialization. It has therefore
been proposed that the three mammalian UPR pathwayssion that is induced by XBP1. However, XBP1 expres-
sion also increased nuclear size, mitochondrial mass, have diverged functionally during evolution (Figure 7;
Calfon et al., 2002; Harding et al., 2002), and our dataand lysosomal content, suggesting that the cell size
phenotype is part of a coordinated increase in multiple strongly support this hypothesis.
XPB1 has retained important features of its yeast or-intracellular structures. These functional capabilities of
XBP1 have not been reported for HAC1, suggesting that tholog HAC1, while developing additional functions that
promote development of the secretory phenotype. LikeXBP1 has acquired additional regulatory roles during
evolution. HAC1, XBP1 transactivated a host of genes encoding
proteins that function throughout the secretory path-The mechanism by which XBP1 exerts such pleiotro-
pic effects on cellular organelles is not clear at present. way. Further, our experiments revealed that XBP1 is
sufficient to expand the ER in a wide variety of mamma-Not only did mitochondrial mass increase but so did
mitochondrial function, as assessed by the mitochon- lian cells, which may be functionally analogous the
HAC1-mediated formation of ER-like karmellae.drial membrane potential. Two XBP1 target genes,
cox15 and ndufa1, encode proteins that are required for However, XBP1 has acquired new functional capabili-
ties that have not been reported for HAC1. Most notably,electron transport in the mitochondrion (Antonicka et
al., 2003; Yadava et al., 2002), and the XBP1 target gene we found that XBP1 increased overall protein synthesis,
which clearly would favor high-level protein secretion.acas2l encodes a mitochondrial enzyme that synthe-
sizes acetyl-CoA for use in oxidation. However, it is In marked contrast, PERK signaling inhibits protein
translation, a clearly undesirable attribute for a secretorynot know whether the increased expression of these
mitochondrial proteins would stimulate respiration or cell. Indeed, it is possible that XBP1 evolved in order
for professional secretory cells to modulate the activitywhether they play a role in the XBP1-induced increase
in mitochondrial mass. Three XBP1 target genes encode of PERK. In this regard, it is notable that the PERK
pathway upregulates chop (Harding et al., 2000; Yan etlysosomal proteins involved in lipid hydrolysis (lipa), fu-
sion of autophagic vesicles with the lysosome (lamp2), al., 2002), which encodes a mediator of apoptosis during
ER stress, whereas the IRE1/XBP1 pathway does notand possibly in small molecule transport into the lyso-
some (laptm4a). Again, it is not known whether upregula- (this study and Gass et al. [2002]; Lee et al. [2003]). Thus,
PERK serves as a checkpoint protein during ER stresstion of these lysosomal proteins can account for the
increased lysosomal biogenesis in XBP1-expressing that can decrease the unfolded protein load in the ER
by inhibiting translation or eliminate the cell if the ERcells.
Another unanticipated observation was that XBP1 in- stress is severe and prolonged. XBP1, on the other hand,
has apparently evolved to promote translation by antag-creased protein synthesis globally by 30%–50%, which
could contribute to the increase in organelle content onizing PERK, thereby allowing cells to differentiate into
professional secretory cells that can tolerate a constitu-and cell size. XBP1-s increased the synthesis of both
nonglycosylated and glycosylated proteins equivalently. tively high throughput of ER proteins.
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Flow Cytometry and MicroscopyIt may therefore be helpful to define a “physiological”
Please see http://lymphochip.nih.gov/ShafferPCfactors/. For deter-UPR (Gass et al., 2002) that is activated constitutively in
mination of protein synthesis, degradation, and ribosome content,professional secretory cells through the action of XBP1,
please see http://lymphochip.nih.gov/ShafferPCfactors/.
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